Abstract
Background. The B2-bradykinin receptor (BDKRB2) has been reported to associate with onset and development of Osteoarthritis (OA); however, the role of BDKRB2 genetic polymorphisms in OA remains unknown. Method. A total of 245 patients with primary knee OA and 264 healthy volunteer were recruited. BDKRB2 gene polymorphisms, -58T/C and +9/-9 bp polymorphisms, were genotyped. Results. The genotype distributions and allele frequencies of +9/-9 bp polymorphisms significantly differed between OA and control subjects. Logistic regression analysis showed carriers with -9/-9 genotype had a significantly increased risk for knee OA compared with the +9/+9 genotype (adjusted OR=2.356, P<0.001). The OR for -9 allele carriage was significantly higher than +9 allele carriage (adjusted OR=1.52, P<0.001). The +9/-9 bp polymorphisms also determined the OA radiographic severity. The presence of -9 bp was associated with severer OA. The -58T/C polymorphisms did not affect OA risk and severity. Conclusion. The +9/-9 bp polymorphisms of BDKRB2 gene may be used as a genetic marker for the susceptibility and severity of OA. © 2012 Shuo Chen et al.
Cite
CITATION STYLE
Chen, S., Zhou, Y., Li, J., Shan, L. Q., & Fan, Q. Y. (2012). The effect of bradykinin B2 receptor polymorphisms on the susceptibility and severity of osteoarthritis in a Chinese cohort. Journal of Biomedicine and Biotechnology, 2012. https://doi.org/10.1155/2012/597637
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.